05/27/2026
How can regulation evolve to accelerate innovation while strengthening patient safety?
That question takes center stage at the 2026 UK Forum in London on June 11, bringing together leading voices from across healthcare, policy, and life sciences.
Among the featured discussions is “Regulation reinvented: Accelerating approvals and enhancing patient safety,” chaired by Lawrence Tallon, Chief Executive of the Medicines and Healthcare products Regulatory Agency, with insights from an expert panel, including:
• Alastair Denniston, MBBChir, MRCP, FRCOphth, PhD, Chair of Regulatory Science and Innovation, University of Birmingham; Non-Executive Director, Health Research Authority; AI Strategic Advisor, Health Data Research UK; Director, Centre of Excellence for Regulatory Science in AI & Digital HealthTech (CERSI-AI)
• Petra Doerr, PhD, Director, EDQM - Council of Europe
• Johanna Furuhjelm, PhD, Director, Centre for AI Innovation, Karolinska Institutet
• Hilary M Malone PhD, CEO, CorriXR Therapeutics